Experimental Treatment Denials: Your Rights Under ERISA

"Experimental and investigational" is the denial reason insurers reach for when they want to deny a treatment that has real clinical evidence behind it but costs a lot. The label is often applied selectively and incorrectly — and it is one of the most successfully appealed denial types.

What Makes a Treatment "Experimental"?

There's no universal legal definition. Each insurer sets its own criteria, which typically include:

• The treatment is still in clinical trials
• The FDA has not approved it for your specific indication
• There is insufficient peer-reviewed evidence supporting its use
• Professional medical societies have not endorsed it as standard of care

The problem: insurers apply these criteria inconsistently. A treatment can have FDA approval, published Phase III trial data, and guidelines from three major societies — and still get labeled experimental by an automated review system.

Your Rights Under ERISA

If your coverage comes through an employer, your plan is almost certainly governed by ERISA (Employee Retirement Income Security Act). Under ERISA:

• You have the right to a full and fair review of any denied claim
• The insurer must provide specific reasons for denial in writing
• You must be given access to all documents, records, and clinical criteria used in the decision
• You have at least 180 days to file an internal appeal
• If your internal appeal is denied, you have the right to external review under the ACA (for non-grandfathered plans)

Crucially, ERISA also allows you to sue the plan administrator in federal court if your appeal is denied and you've exhausted internal remedies. This is a meaningful threat that some insurers take seriously.

How to Challenge an Experimental Denial

Step 1: Request the exact criteria used

Ask for the specific clinical criteria, guidelines, or technology assessments the insurer used to classify your treatment as experimental. They are required to provide these. Often, these documents themselves contain exceptions or outdated evidence that you can challenge.

Step 2: Compile evidence that the treatment is not experimental

Gather documentation showing the treatment is accepted medical practice:

• FDA approval letters or clearance documents
• Published clinical guidelines from relevant specialty societies (e.g., ASCO for oncology, ACC for cardiology)
• Peer-reviewed studies — prioritize Phase III randomized controlled trials and systematic reviews
• Evidence of widespread clinical use (what percentage of physicians use this treatment?)
• Medicare or Medicaid coverage determinations — if federal programs cover it, "experimental" is hard to justify

Step 3: Address each criterion the insurer cited

Your appeal letter must rebut each specific reason the insurer used. If they said "insufficient peer-reviewed evidence," you cite specific journals. If they said "not endorsed by specialty societies," you provide the guideline page number. Vague rebuttals fail; specific citations win.

State Laws That Protect You Beyond ERISA

Several states have passed laws requiring insurers to cover treatments that are in clinical trials for serious conditions. If you're enrolled in an individual or state-regulated plan (not an ERISA employer plan), check your state's insurance code. States including California, New York, and Illinois have strong clinical trial coverage mandates.

External Review: Your Most Powerful Tool

Experimental treatment denials have among the highest external review overturn rates of any denial category — because an independent clinical expert, not an insurance employee, is evaluating the actual evidence. If your internal appeal is denied, go to external review immediately. The external reviewer's decision is binding on the insurer.